Chimeric antigen receptor (CAR) therapies utilize engineered receptors that are able to redirect immune cells to identify and destroy cancer cells that express a specific antigen. At present, CAR-T ...

As a basic description, an antibody can be described as any molecule that has epitopes (antigenic sites) that fit with corresponding antibodies, initiating an immune response. Antigens come in many ...

Immunohistochemistry uses antibodies to test tissue samples for specific types of antigens. It can often provide very specific results regarding cancer types or other diseases, helping doctors decide ...

The need for effective adjuvant therapies and evidence that the immune system plays a prominent role in the development and progression of melanoma (Curiel-Lewandrowski & Demierre, 2000) have led to ...

A new edition of the EPO Guidelines for Examination (‘the guidelines’) came into force on 1 March 2021. Relevant to life sciences, this edition includes a new subsection detailing EPO practice with ...